41.24

0.10% 0.04

After Hours: 41.24

Inari Medical Inc (NARI)

Overview News Price History Option Chain Financials Why NARI Down? Discussions Forecast

Inari Medical Inc stock is traded at $41.24, with a volume of 808.96K. It is up +0.10% in the last 24 hours and down -4.60% over the past month. Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

Previous Close:

$41.20

Open:

$41.18

24h Volume:

808.96K

Relative Volume:

0.94

Market Cap:

$2.39B

Revenue:

$547.47M

Net Income/Loss:

$-57.05M

P/E Ratio:

-687.33

EPS:

-0.06

Net Cash Flow:

$16.91M

1W Performance:

-4.47%

1M Performance:

-4.60%

6M Performance:

-14.05%

1Y Performance:

-36.94%

1-Day Range:

$40.75

$42.30

1-Week Range:

$40.42

$43.78

52-Week Range:

$36.73

$69.40

Inari Medical Inc Stock (NARI) Company Profile

Name

Inari Medical Inc

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

949-923-4747

Address

6001 OAK CANYON, SUITE 100, IRVINE, CA

Employee

1,300

Twitter

@InariMedical

Next Earnings Date

2024-10-30

Latest SEC Filings

NARI's Discussions on Twitter

Inari Medical Inc Stock (NARI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-23-24	Initiated	Needham	Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Oct-12-22	Initiated	Jefferies	Buy
Sep-29-22	Initiated	Berenberg	Buy
Sep-13-22	Initiated	Truist	Hold
Jun-21-22	Initiated	Piper Sandler	Overweight
Mar-23-22	Resumed	BofA Securities	Buy
Dec-15-20	Upgrade	Wells Fargo	Equal Weight → Overweight
Nov-18-20	Initiated	BTIG Research	Buy
Oct-29-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-28-20	Initiated	SVB Leerink	Outperform
Jun-19-20	Initiated	Canaccord Genuity	Buy
Jun-16-20	Initiated	BofA/Merrill	Neutral
Jun-16-20	Initiated	Morgan Stanley	Equal-Weight
Jun-16-20	Initiated	Wells Fargo	Equal Weight

View All

Inari Medical Inc Stock (NARI) Latest News

Sep 29, 2024

Renaissance Technologies LLC Cuts Stock Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat

Sep 29, 2024

Inari Medical, Inc. (NASDAQ:NARI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Sep 29, 2024

Sep 28, 2024

Lighthouse Investment Partners LLC Makes New Investment in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat

Sep 28, 2024

Sep 26, 2024

Fred Alger Management LLC Reduces Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat

Sep 26, 2024

Sep 25, 2024

McDermott + Bull Assists Inari Medical with CTO Search - Hunt Scanlon Media

Sep 25, 2024

Affinity Asset Advisors LLC Buys 25,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat

Sep 25, 2024

Sep 24, 2024

First Light Asset Management LLC Has $22.75 Million Holdings in Inari Medical, Inc. (NASDAQ:NARI) - Defense World

Sep 24, 2024

First Light Asset Management LLC Acquires 258,444 Shares of Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat

Sep 24, 2024

Sep 23, 2024

Integral Health Asset Management LLC Has $19.26 Million Stock Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat

Sep 23, 2024

Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues - Simply Wall St

Sep 23, 2024

Sep 22, 2024

Commonwealth Equity Services LLC Invests $421,000 in Inari Medical, Inc. (NASDAQ:NARI) - Defense World

Sep 22, 2024

Sep 21, 2024

Trading (NARI) With Integrated Risk Controls - Stock Traders Daily

Sep 21, 2024

Sep 19, 2024

Kaskela Law LLC Announces Shareholder Investigation of - GlobeNewswire

Sep 19, 2024

Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages - EIN News

Sep 19, 2024

Sep 18, 2024